• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Crennen Lyndsey Elizabeth claimed ownership of 1,863 shares (SEC Form 3)

    6/16/26 4:47:53 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials
    Get the next $MLAB alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Crennen Lyndsey Elizabeth

    (Last)(First)(Middle)
    2850 S CLARKSON CIRCLE

    (Street)
    ENGLEWOOD COLORADO 80113

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    06/15/2026
    3. Issuer Name and Ticker or Trading Symbol
    MESA LABORATORIES INC /CO/ [ MLAB ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    Chief Accounting Officer
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock1,863D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Restricted Stock Unit - 1(3)06/21/2026(1) (2)Common Stock125$0D
    Restricted Stock Unit - 2(3)06/18/2026(4) (2)Common Stock465$0D
    Restricted Stock Units - 3(3)06/19/2026(5) (2)Common Stock735$0D
    Restricted Stock Units(3)06/13/2027(6) (2)Common Stock542$0D
    Restricted Stock Units - 503/02/2027(7) (2)Common Stock1,800$0D
    Restricted Stock Units 6(3)06/15/2027(8) (2)Common Stock1,443$0D
    NSO -109/01/2022(9)09/01/2027Common Stock369$268.85D
    NSO - 206/15/2025(10)06/15/2028Common Stock488$185.57D
    NSO - 306/21/2024(11)06/21/2029Common Stock646$131.67D
    Explanation of Responses:
    1. Last tranche of the grant vests on June 21, 2026
    2. Not Applicable
    3. Each RSU represents a contingent right to receive one share of the Issuer's common stock
    4. RSUs that vest 233 shares on June 18, 2026 and 232 shares that vest on June 18, 2027
    5. RSUs that vest 368 shares on June 19, 2026 and 367 shares that vest on June 19, 2027
    6. RSUs that vest 271 shares on June 13, 2027 and 271 shares on June 13, 2028
    7. RSUs that vest 612 shares on March 2, 2027 and 594 shares that vest on each of March 2, 2028 and March 2, 2029
    8. RSUs that vest 34% on June 15, 2027, 33% on June 8, 2028 and 33% on June 8, 2029
    9. Non qualified stock options that were fully vested as of June 15, 2024
    10. Non qualified stock options that were fully vested as of June 15, 2025
    11. NSO's that will fully vest on June 21, 2026
    John Sakys under Power of Attorney by Lyndsey Crennen06/16/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $MLAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MLAB

    DatePrice TargetRatingAnalyst
    8/7/2025$67.00Underweight → Equal Weight
    Wells Fargo
    8/28/2024$120.00Underweight
    Wells Fargo
    1/4/2024$100.00 → $125.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $MLAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 5:43:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Capone Mark Christopher bought $99,331 worth of shares (1,301 units at $76.35), increasing direct ownership by 61% to 3,429 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:46:59 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Tripeny R Tony bought $99,940 worth of shares (1,315 units at $76.00), increasing direct ownership by 32% to 5,398 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 3:39:49 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CAO Crennen Lyndsey Elizabeth sold $39,560 worth of shares (442 units at $89.50), exercised 726 shares at a strike of $95.10 and was granted 263 shares, increasing direct ownership by 37% to 2,020 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    6/23/26 1:34:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SVP Operations Archbold Brian David exercised 3,324 shares at a strike of $95.10, was granted 1,859 shares and sold $225,187 worth of shares (2,516 units at $89.50), increasing direct ownership by 72% to 6,377 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    6/23/26 1:02:33 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    CFO Sakys John exercised 3,792 shares at a strike of $95.10, was granted 2,282 shares and sold $253,022 worth of shares (2,827 units at $89.50) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 19,785 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    6/23/26 12:23:10 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    SEC Filings

    View All

    SEC Form DEF 14A filed by Mesa Laboratories Inc.

    DEF 14A - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    7/22/26 2:55:07 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    6/15/26 5:29:57 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form S-8 filed by Mesa Laboratories Inc.

    S-8 - MESA LABORATORIES INC /CO/ (0000724004) (Filer)

    6/3/26 8:23:01 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mesa Laboratories upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Mesa Laboratories from Underweight to Equal Weight and set a new price target of $67.00

    8/7/25 7:05:04 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Wells Fargo initiated coverage on Mesa Laboratories with a new price target

    Wells Fargo initiated coverage of Mesa Laboratories with a rating of Underweight and set a new price target of $120.00

    8/28/24 7:48:06 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Mesa Laboratories from In-line to Outperform and set a new price target of $125.00 from $100.00 previously

    1/4/24 8:29:10 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MESA LABS DECLARES QUARTERLY DIVIDEND

    Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, inc

    7/6/26 9:50:22 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

    LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q26") and fiscal year ("FY26") ended March 31, 2026 (amounts in thousands). 4Q26 Financial Summary – (comparisons are versus the same prior year period) Revenues increased 2.6%Non-GAAP organic and core organic revenues1 growth was 2.6% and (0.6)%, respectivelyOperating income increased 87% to $2,748Non-GAAP adjusted operating income ("AOI") excluding unusual items2 increased 49.2% and was 28.7% as a percentag

    5/27/26 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026

    LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026. About Mesa LaboratoriesMesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. Mesa Laboratories C

    5/5/26 1:39:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Leadership Updates

    Live Leadership Updates

    View All

    Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

    LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter ("4Q26") and fiscal year ("FY26") ended March 31, 2026 (amounts in thousands). 4Q26 Financial Summary – (comparisons are versus the same prior year period) Revenues increased 2.6%Non-GAAP organic and core organic revenues1 growth was 2.6% and (0.6)%, respectivelyOperating income increased 87% to $2,748Non-GAAP adjusted operating income ("AOI") excluding unusual items2 increased 49.2% and was 28.7% as a percentag

    5/27/26 8:00:00 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO

    LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) --  Mesa Laboratories, Inc. (NASDAQ:MLAB) ("Mesa" or "the Company"), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens will step down as President and CEO on April 12, 2026, and will enable a smooth leadership transition. "Gary has served as Mesa's CEO since 2017, leading Mesa through a period of significant growth, expansion into new markets, the maturation of the company's foundation, and the implementation of The Mesa Way business system," said John Sullivan, Chair of the Board. "We are grateful for his leadership and wish him continued success." T

    3/9/26 4:30:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    $MLAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesa Laboratories Inc.

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    10/15/24 1:29:56 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    2/13/24 5:09:39 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Mesa Laboratories Inc. (Amendment)

    SC 13G/A - MESA LABORATORIES INC /CO/ (0000724004) (Subject)

    1/23/24 2:18:26 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    $MLAB
    Financials

    Live finance-specific insights

    View All

    MESA LABS DECLARES QUARTERLY DIVIDEND

    Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, inc

    7/6/26 9:50:22 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., April 02, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase pa

    4/2/26 6:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    MESA LABS DECLARES QUARTERLY DIVIDEND

    LAKEWOOD, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2026, to shareholders of record at the close of business on February 28, 2026. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increa

    1/7/26 5:00:00 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials